GTN Company
GTN innovates a quantum machine learning technology to transform drug discovery.
Investors
Total Funding:
2100000.0
Headquarters:
London, England, United Kingdom
Funding Status:
Seed
Employee Number:
1-10
Estimated Revenue:
$1M to $10M
Last Funding Type:
Seed
Technology:
Developing Software
Last Funding Date:
2018-11-01
Investors Number:
6.0
Founded Date:
2017-05-17
Industry:
Application Software